Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

Share Price is delayed by 15 minutes
Get Live Data
16.50    0.00 (0.00%)
Bid:
14.00
Ask:
19.00
Spread: 5.00 (35.714%)
Market Cap: £16.76m
TMG Live PriceLast checked at - London Stock Exchange

Intraday The Mission Group Share Chart

Form 8.3 - The Mission Group plc

14 May 2024 14:21

Form 8.3 - The Mission Group plc

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:OCTOPUS INVESTMENTS LTD
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. 
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeThe Mission Group plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: 
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure13/05/2024
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary 1p (GB00B11FD453)
 InterestsShort positions
 Number%Number%
(1) Relevant securities owned and/or controlled: 3,862,327 4.19   
(2) Cash-settled derivatives:     
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL:3,862,3274.19  

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/sale Number of securitiesPrice per unit
Ordinary 10p Ordinary 10p Ordinary 10p Ordinary 10p Ordinary 10p Ordinary 10pSale Sale Sale Sale Sale Sale4,507 81,403 414,090 165,636 1,803 32,5610.23 0.23 0.23 0.23 0.23 0.23

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
     

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
        

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
     

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
    
    

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:14/05/2024
Contact name:Kelly Lake
Telephone number/email:Kelly.lake@octopusinvestments.com

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
15th Jun 20261:00 pmRNSResult of AGM
15th Jun 20267:00 amRNSAGM Trading Update
4th Jun 20267:00 amRNSNotice of AGM and Posting of Annual Report
21st May 202611:46 amRNSDirector/PDMR Shareholding
1st May 20262:45 pmRNSHolding(s) in Company
28th Apr 202611:00 amRNSHolding(s) in Company
27th Mar 20264:50 pmRNSHolding(s) in Company
24th Mar 20267:00 amRNSFinal Results
20th Mar 202612:00 pmRNSNotice of Investor Presentation
18th Feb 20267:00 amRNSGrowth Share Scheme
13th Jan 20267:00 amRNSBoard Changes
13th Jan 20267:00 amRNSFull Year Trading Update
17th Oct 20257:00 amRNSDirectorate Change
10th Oct 20257:00 amRNSDirector/PDMR Shareholding
23rd Sep 20257:00 amRNSINTERIM RESULTS FOR THE SIX MONTHS TO 30 JUNE 2025
12th Sep 20257:00 amRNSBOARD CHANGES
22nd Aug 20257:00 amRNSNOTICE OF RESULTS AND INVESTOR PRESENTATION
12th Aug 20254:22 pmRNSHolding(s) in Company
6th Aug 20256:24 pmRNSHolding(s) in Company
24th Jul 20257:00 amRNSTrading Update
1st Jul 20257:00 amRNSMISSION Group plc appoints John Carey as new CEO
16th Jun 20251:19 pmRNSResult of AGM
16th Jun 20257:00 amRNSAGM Trading Update
11th Jun 202511:44 amRNSNotice of AGM and Posting of Annual Report
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 202510:16 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024
10th Mar 20257:00 amRNSInvestor Presentation
17th Feb 20257:00 amRNSTransaction in Own Shares
11th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares
24th Jan 20257:00 amRNSTransaction in Own Shares
23rd Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20258:00 amRNSTransaction in Own Shares
21st Jan 20257:00 amRNS2024 Full Year Trading Update
13th Jan 20259:30 amRNSHolding(s) in Company
10th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
6th Jan 20253:47 pmRNSHolding(s) in Company
6th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSDirector/PDMR Shareholding
2nd Jan 20257:00 amRNSDirectorate Change
2nd Jan 20257:00 amRNSShare buyback programme
2nd Jan 20257:00 amRNSDisposal and Capital Allocation Update
21st Nov 20247:00 amRNSDirectorate Change
24th Sep 20247:00 amRNSINTERIM RESULTS FOR THE SIX MONTHS TO 30 JUNE 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.